CLINICAL_TRIALS
trial_result
· 2025-02-05
Clinical Trial Update: 2 Dose Neuraxial Morphine for Prevention of PDPH [Phase 4]
Summary
A Phase 4 trial evaluated whether two doses of neuraxial morphine can prevent postdural puncture headache. The study is completed and results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Columbia University | Conditions: Postdural Puncture Headache | Phase 4 | Status: COMPLETED | Results posted: 2025-02-05